Grant: Discovery Grants Program - Individual
University of Alberta
$64,000.00
Posttranslational regulation of the SLC29A family of nucleoside transporters
FY 2024-25
Summary
Our body is made up of individual units called 'cells'. Each cell has a specialized function. Cells have an outer membrane that forms a barrier to many substances. In order for cells to take up the nutrients from the blood that they need to survive and grow, they must rely on specific molecules (proteins) in the cell membrane to facilitate the passage of these nutrients into the cell. We are studying one particular type of these "transport" proteins involved in the cellular uptake and release of nucleosides. Nucleosides are a class of substances that are used as the building blocks for DNA and RNA, and are also important for controlling many other aspects of cell function. Cells require different levels of nucleosides at different times, and must adapt to their environment to ensure that the nucleoside concentrations, both inside and outside the cell, are maintained at specific levels. We are studying this cellular adaptation process. Our studies are focused on how cells regulate the number and activity of "nucleoside transporters". An increase or decrease in nucleoside transporter activity has been known to modify blood flow to tissues, protect the heart and brain tissue from damage during transient ischemic episodes, and modify the duration of seizures. Nucleoside transporters are also important for the activity of a number of anticancer and antiviral drugs that get into the tumour cells or virus-infected cells via these transporters. A better understanding of how the body regulates nucleoside transporters will enhance our ability to develop better therapies for conditions such as heart failure, seizures, and stroke. These studies will also enhance our understanding of how the cell regulates its metabolism in response to environmental influences.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-04046
Name nom
Hammond, James
Department département
Pharmacology - Pharmacology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5109
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Intra-cellular targeting
Research subject fr
Cibles intra-cellulaires
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Posttranslational regulation of the SLC29A family of nucleoside transporters
Keywords
transporters; protein modification; nucleosides; protein trafficking; metabolism; adenosine
Application summary
Our body is made up of individual units called 'cells'. Each cell has a specialized function. Cells have an outer membrane that forms a barrier to many substances. In order for cells to take up the nutrients from the blood that they need to survive and grow, they must rely on specific molecules (proteins) in the cell membrane to facilitate the passage of these nutrients into the cell. We are studying one particular type of these "transport" proteins involved in the cellular uptake and release of nucleosides. Nucleosides are a class of substances that are used as the building blocks for DNA and RNA, and are also important for controlling many other aspects of cell function. Cells require different levels of nucleosides at different times, and must adapt to their environment to ensure that the nucleoside concentrations, both inside and outside the cell, are maintained at specific levels. We are studying this cellular adaptation process. Our studies are focused on how cells regulate the number and activity of "nucleoside transporters". An increase or decrease in nucleoside transporter activity has been known to modify blood flow to tissues, protect the heart and brain tissue from damage during transient ischemic episodes, and modify the duration of seizures. Nucleoside transporters are also important for the activity of a number of anticancer and antiviral drugs that get into the tumour cells or virus-infected cells via these transporters. A better understanding of how the body regulates nucleoside transporters will enhance our ability to develop better therapies for conditions such as heart failure, seizures, and stroke. These studies will also enhance our understanding of how the cell regulates its metabolism in response to environmental influences.